These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 10745623

  • 1. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
    Takeshita A, Saito H, Toyama K, Horiuchi A, Kuriya S, Furusawa S, Tsuruoka N, Takiguchi T, Matsuda T, Utsumi M, Shiku H, Matsui T, Egami K, Tamura K, Ohno R.
    Int J Hematol; 2000 Feb; 71(2):136-43. PubMed ID: 10745623
    [Abstract] [Full Text] [Related]

  • 2. A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group.
    Dombret H, Chastang C, Fenaux P, Reiffers J, Bordessoule D, Bouabdallah R, Mandelli F, Ferrant A, Auzanneau G, Tilly H.
    N Engl J Med; 1995 Jun 22; 332(25):1678-83. PubMed ID: 7539109
    [Abstract] [Full Text] [Related]

  • 3. [A randomized double-blind controlled study of recombinant human granulocyte colony-stimulating factor in patients with neutropenia induced by consolidation chemotherapy for acute myeloid leukemia. (rG.CSF clinical study group)].
    Takeshita A, Ohno R, Hirashima K, Toyama K, Okuma M, Saito H, Ikeda Y, Tomonaga M, Asano S.
    Rinsho Ketsueki; 1995 Jun 22; 36(6):606-14. PubMed ID: 7543956
    [Abstract] [Full Text] [Related]

  • 4. A randomized controlled study of granulocyte colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia. Japan Adult Leukemia Study Group.
    Ohno R, Tomonaga M, Ohshima T, Masaoka T, Asou N, Oh H, Nishikawa K, Kanamaru A, Murakami H, Furusawa S.
    Int J Hematol; 1993 Aug 22; 58(1-2):73-81. PubMed ID: 7693029
    [Abstract] [Full Text] [Related]

  • 5. Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial.
    Schmitz N, Ljungman P, Cordonnier C, Kempf C, Linkesch W, Alegre A, Solano C, Simonsson B, Sonnen R, Diehl V, Fischer T, Caballero D, Littlewood T, Noppeney R, Schafhausen P, Jost L, Delabarre F, Marcus R.
    Bone Marrow Transplant; 2004 Dec 22; 34(11):955-62. PubMed ID: 15489865
    [Abstract] [Full Text] [Related]

  • 6. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L, Nathan PC, Lange B, Beyene J, Buchanan GR.
    J Clin Oncol; 2004 Aug 15; 22(16):3350-6. PubMed ID: 15310780
    [Abstract] [Full Text] [Related]

  • 7. Low-dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood progenitor cell rescue.
    Nolan L, Lorigan P, Chilton S, Newman J, Else R, Smith P, Linch D, Sweetenham JW, Johnson PW.
    Br J Haematol; 2007 Jun 15; 137(5):436-42. PubMed ID: 17433027
    [Abstract] [Full Text] [Related]

  • 8. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
    Todisco E, Castagna L, Sarina B, Mazza R, Magagnoli M, Balzarotti M, Nozza A, Siracusano L, Timofeeva I, Anastasia A, Demarco M, Santoro A.
    Eur J Haematol; 2007 Feb 15; 78(2):111-6. PubMed ID: 17313558
    [Abstract] [Full Text] [Related]

  • 9. Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia--a randomized, placebo-controlled, double-blind safety and efficacy study.
    Geissler K, Yin JA, Ganser A, Sanz MA, Szer J, Raghavachar A, Hoelzer D, Martinez C, Taylor K, Kanz L, To LB, Archimbaud E.
    Ann Hematol; 2003 Nov 15; 82(11):677-83. PubMed ID: 14530872
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF)--results of a prospective randomised monocentre study.
    Bönig H, Silbermann S, Weller S, Kirschke R, Körholz D, Janssen G, Göbel U, Nürnberger W.
    Bone Marrow Transplant; 2001 Aug 15; 28(3):259-64. PubMed ID: 11535993
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M, Karasawa M, Naruse T, Fukuda M, Hirashima K, Oh H, Ninomiya H, Abe T, Saito K, Shishido H, Moriyama Y, Shibata A, Motoyoshi K, Nagata N, Miura Y.
    Int J Hematol; 1999 Feb 15; 69(2):81-8. PubMed ID: 10071455
    [Abstract] [Full Text] [Related]

  • 18. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
    Creutzig U, Zimmermann M, Lehrnbecher T, Graf N, Hermann J, Niemeyer CM, Reiter A, Ritter J, Dworzak M, Stary J, Reinhardt D.
    J Clin Oncol; 2006 Sep 20; 24(27):4499-506. PubMed ID: 16983120
    [Abstract] [Full Text] [Related]

  • 19. A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma.
    Seymour AM, de Campos E, Thatcher N, De Greve J, Cunningham D, Howell A, Tueni E, Bron DG, Steward WP, Berdel WE.
    Eur J Cancer; 1995 Dec 20; 31A(13-14):2157-63. PubMed ID: 8652235
    [Abstract] [Full Text] [Related]

  • 20. Cost benefit and clinical efficacy of low-dose granulocyte colony-stimulating factor after standard chemotherapy in patients with non-Hodgkin's lymphoma.
    Hashino S, Morioka M, Irie T, Shiroshita N, Kawamura T, Suzuki S, Iwasaki H, Umehara S, Kakinoki Y, Kurosawa M, Kahata K, Izumiyama K, Kobayashi H, Onozawa M, Takahata M, Fujisawa F, Kondo T, Asaka M.
    Int J Lab Hematol; 2008 Aug 20; 30(4):292-9. PubMed ID: 18665826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.